Advertisement
Screener

Cellcyte Genetics Corp. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

Cellcyte Genetics Corp. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

Cellcyte Genetics Corp. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$35.27 thousand for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.

Discontinued › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2013-05-15

  • Cellcyte Genetics Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2013-03-31 was -$35.27K.
  • Cellcyte Genetics Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2012-12-31 was $526.03K.
  • Cellcyte Genetics Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2012-09-30 was -$34.94K.
  • Cellcyte Genetics Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2012-06-30 was $130.44K.
  • Cellcyte Genetics Corp. net income (loss), including portion attributable to noncontrolling interest for fiscal 2012 was $585.83K.
  • Cellcyte Genetics Corp. net income (loss), including portion attributable to noncontrolling interest for fiscal 2011 was -$359.40K.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 48 month
2013-03-31-$35.27K
10-Q · filed 2013-05-15
$490.76K
derived: sum of 2 quarters · filed 2013-05-15
$455.82K
derived: sum of 3 quarters · filed 2013-05-15
-$12.56M
10-Q · filed 2013-05-15
2012-12-31$526.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-12
$491.09K
derived: sum of 2 quarters · filed 2013-04-12
$621.53K
derived: sum of 3 quarters · filed 2013-04-12
$585.83K
10-K · filed 2013-04-12
-$12.52M
10-K · filed 2013-04-12
2012-09-30-$34.94K
10-Q · filed 2012-11-14
$95.50K
derived: sum of 2 quarters · filed 2012-11-14
$59.79K
10-Q · filed 2012-11-14
-$13.05M
10-Q · filed 2012-11-14
2012-06-30$130.44K
10-Q · filed 2012-08-14
$94.73K
10-Q · filed 2012-08-14
-$112.49K
derived: sum of 3 quarters · filed 2013-05-15
-$13.01M
10-Q · filed 2012-08-14
2012-03-31-$35.70K
10-Q · filed 2013-05-15
-$242.93K
derived: sum of 2 quarters · filed 2013-05-15
-$285.56K
derived: sum of 3 quarters · filed 2013-05-15
-$350.26K
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31-$207.22K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-12
-$249.86K
derived: sum of 2 quarters · filed 2013-04-12
-$314.56K
derived: sum of 3 quarters · filed 2013-04-12
-$359.40K
10-K · filed 2013-04-12
2011-09-30-$42.63K
10-Q · filed 2012-11-14
-$107.33K
derived: sum of 2 quarters · filed 2012-11-14
-$152.18K
10-Q · filed 2012-11-14
2011-06-30-$64.70K
10-Q · filed 2012-08-14
-$109.54K
10-Q · filed 2012-08-14